By Josh White
Date: Thursday 31 Oct 2024
(Sharecast News) - Hutchmed China announced on Thursday that it was set to receive a $20m milestone payment from its partner Takeda, after sales of 'Fruzaqla', or fruquintinib, surpassed $200m.
Appointment of Independent Non-executive Director | 20-Nov-2024 | 09:30 | RNS |
Total Voting Rights | 31-Oct-2024 | 08:30 | RNS |
Vesting of awards under the LTIP | 21-Oct-2024 | 09:30 | RNS |
SAVANNAH: clinically meaningful response rate | 16-Oct-2024 | 07:00 | RNS |
Japan Approval for FRUZAQLA | 24-Sep-2024 | 08:00 | RNS |
Chinese medicine firm employs Cambridge Universi... | 23-Dec-2009 | Guardian |
Joint venture offers food for growth | 09-Oct-2009 | The Scotsman |
Chi-Med unveils maiden profit | 31-Jul-2009 | The Scotsman |
Chi-Med happy with drug tests | 14-Jul-2009 | The Scotsman |
'Watershed' year depends on US drugs trial says ... | 17-Mar-2009 | The Scotsman |
Questor: Hutchison China Meditech | 03-Jul-2007 | Telegraph |
The Week Ahead: Wolseley investors seek calm ami... | 19-Mar-2007 | The Independent |
The Investment Column: Hutchison China MediTech | 21-Nov-2006 | The Independent |
Shares That Sound Good | 02-Jun-2006 | Motley Fool UK |
No recent information was found.
Currency | UK Pounds |
Share Price | 281.00p |
Change Today | -3.00p |
% Change | -1.06 % |
52 Week High | 352.00 |
52 Week Low | 192.40 |
Volume | 30,671 |
Shares Issued | 871.56m |
Market Cap | £2,449.09m |
Beta | 1.20 |
RiskGrade | 226 |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
No dividends found |
Time | Volume / Share Price |
16:15 | 175 @ 281.88p |
16:12 | 154 @ 281.00p |
16:12 | 125 @ 281.00p |
16:12 | 475 @ 281.00p |
16:12 | 436 @ 281.00p |
You are here: research